Sante Capital Fund’s Pfizer PFE Stock Holding History

Sante Capital Fund’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.15M	Buy	+26,229	New	+$1.27M	2.35%	8

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sante Capital Fund's PFE Position: Q3 2022 in Review

Sante Capital Fund opened a new position in Pfizer (PFE) in Q3 2022: 26,229 shares worth $1.15M. The stake represents 2.35% of the portfolio and ranks #8 among its holdings.

3,086 funds tracked by Wall St. Rank hold PFE as of Q3 2022.

Sante Capital Fund held 26,229 shares of Pfizer worth $1.15M as of Q3 2022.
Pfizer was a new Sante Capital Fund position in Q3 2022.
Pfizer made up 2.35% of Sante Capital Fund's portfolio in Q3 2022, its #8 holding.
3,086 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.

Based on Sante Capital Fund's 13F filing for Q3 2022, filed 14 Nov 2022.